An expression signature model to predict lung adenocarcinoma-specific survival

about

An expression signature model to predict lung adenocarcinoma-specific survival

Item

http://www.wikidata.org/entity/Q57070180

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

An expression signature model to predict lung adenocarcinoma-specific survival

@en

An expression signature model to predict lung adenocarcinoma-specific survival

@nl

type

Item

label

An expression signature model to predict lung adenocarcinoma-specific survival

@en

An expression signature model to predict lung adenocarcinoma-specific survival

@nl

prefLabel

An expression signature model to predict lung adenocarcinoma-specific survival

@en

An expression signature model to predict lung adenocarcinoma-specific survival

@nl

P1476

An expression signature model to predict lung adenocarcinoma-specific survival

@en

P2093

Allen M Chen

http://www.w3.org/2001/XMLSchema#string

Haibing Xian

http://www.w3.org/2001/XMLSchema#string

Haiyun Mo

http://www.w3.org/2001/XMLSchema#string

Haoming Tan

http://www.w3.org/2001/XMLSchema#string

Jiexia Zhang

http://www.w3.org/2001/XMLSchema#string

Kailing Huang

http://www.w3.org/2001/XMLSchema#string

Viola Yingjun Luo

http://www.w3.org/2001/XMLSchema#string

Xiaobing Le

http://www.w3.org/2001/XMLSchema#string

Xiaoshun Shi

http://www.w3.org/2001/XMLSchema#string

Xiaoxiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression analysis for sequence count data

Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis

Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis

The emergence of lncRNAs in cancer biology

First-line crizotinib versus chemotherapy in ALK-positive lung cancer.

MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer

The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus.

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.

Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma.

P304

3717-3732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S159563

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30288103

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

6161724

http://www.w3.org/2001/XMLSchema#string